Researchers are undertaking a comprehensive review to evaluate the effectiveness of various treatments for orthostatic hypotension (OH) in patients with Parkinson’s disease (PD). The protocol for this systematic review and network meta-analysis, authored by LI K, WU L, CUI X, ZHANG W, JI J, WU Y, WANG Z, LIU H, WU H, and ZHU L, was published in the Cochrane Database of Systematic Reviews.

Orthostatic hypotension, a frequent non-motor symptom of Parkinson’s disease, involves a sudden drop in blood pressure upon standing, leading to dizziness, lightheadedness, and even fainting. This condition can substantially impair the quality of life for individuals with PD and increase the risk of falls.

Study aims and Methods

“Orthostatic hypotension…can significantly impair the quality of life for individuals with PD and increase the risk of falls.”

The systematic review aims to synthesize available evidence from randomized controlled trials (RCTs) to compare different interventions for OH in PD. The network meta-analysis will allow for the simultaneous comparison of multiple treatments,even those that have not been directly compared in head-to-head trials.

The researchers will search several major databases, including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and others, to identify relevant studies. They will assess the quality of included trials using established risk of bias assessment tools. Data extraction will be performed independently by multiple reviewers, and any disagreements will be resolved through discussion.

Expected Outcomes

The findings of this review are expected to provide valuable insights into the comparative effectiveness of different treatments for OH in PD.This information can help clinicians make more informed decisions about the management of this challenging condition. Potential interventions include pharmacological treatments, such as midodrine and fludrocortisone, as well as non-pharmacological approaches, such as lifestyle modifications and exercise.

The study protocol emphasizes the importance of addressing OH in PD to improve patient outcomes and reduce the risk of falls and other complications. The results of the network meta-analysis will be disseminated through peer-reviewed publications and presentations at scientific conferences.